glp 1 drug price reduction Medicare Spending on Ozempic and Other GLP-1s Is Skyrocketing The GLP-1 Access Gap: Mapping

and Tonsor, G.T

Designing small molecules able to target multiple receptors might sound difficult, but Septerna says the allosteric binding site it has discovered is even better conserved across all incretin receptors than the site targeted by peptides and other small molecule drugs

If you are currently taking an injectable GLP-1 medication and it is working well for you, there may be no reason to switch

NECC distributed doses of the contaminated steroid injections to 75 medical facilities in 23 states

In patients with ASCVD and BMI 30 kg/m, evolocumab was associated with a greater reduction in major adverse cardiovascular events, with a more favorable NNT compared with normal-weight individuals

They could not care less about the showdown between semaglutide vs tirzepatide or Ozempic vs Zepbound